Olfaction, body mass index, and quality of life with cystic fibrosis combination therapy
Work
Year: 2023
Type: article
Abstract: Triple-combination therapy of elexacaftor-tezacaftor-ivacaftor (ETI) has been shown to reduce morbidity and mortality in people with cystic fibrosis (PwCF). Although patient body mass index (BMI) favo... more
Cites: 16
Cited by: 4
Related to: 10
FWCI: 1.409
Citation percentile (by year/subfield): 75.89
Subfield: Sensory Systems
Field: Neuroscience
Domain: Life Sciences
Sustainable Development Goal Zero hunger
Open Access status: bronze